NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.00 Cr | ₹0.40 Cr | ₹15 Cr | ₹8.00 Cr | ₹1.20 Cr |
What is the latest Contingent Liabilities ratio of NATCO PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.00 Cr |
| Mar2024 | ₹0.40 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹8.00 Cr |
| Mar2021 | ₹1.20 Cr |
How is Contingent Liabilities of NATCO PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.00 Cr | 650.00 | |
| Mar2024 | ₹0.40 Cr | -97.26 | |
| Mar2023 | ₹15 Cr | 82.50 | |
| Mar2022 | ₹8.00 Cr | 566.67 | |
| Mar2021 | ₹1.20 Cr | - | |
Compare Contingent Liabilities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,228.3 Cr | 0.8% | 9.7% | -38.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 0.8% |
9.7% |
-38.4% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses